Protective effects of SIRT1 in patients with proliferative diabetic retinopathy via the inhibition of IL-17 expression

Experimental and Therapeutic Medicine

Volumn 11, Issue 1, 2016, Pages 257-262

  Liu, Shulin ^a   Lin, Yu ^b   Liu, Xin ^b  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Epiretinal membrane; Interleukin 17; Proliferative diabetic retinopathy; Resveratrol; Sirtuin

Indexed keywords

INTERLEUKIN 17; MESSENGER RNA; RESVERATROL; SIRTUIN 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PROLIFERATIVE DIABETIC RETINOPATHY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; VITRECTOMY; WESTERN BLOTTING;

EID: 84949459352     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2877     Document Type: Article

References (38)

1. Hendrick AM, Gibson MV and Kulshreshtha A: Diabetic retinopathy. Prim Care 42: 451-464, 2015.
2. Zhang X, Bao S, Lai D, Rapkins RW and Gillies MC: Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes 57: 1026-1033, 2008.
3. Frank RN: Diabetic retinopathy. N Engl J Med 350: 48-58, 2004.
4. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, et al; Meta-Analysis for Eye Disease (META-EYE) Study Group: Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35: 556-564, 2012.
5. Cheung CM, Vania M, Ang M, Chee SP and Li J: Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy. Mol Vis 18: 830-837, 2012.
6. Giacco F and Brownlee M: Oxidative stress and diabetic complications. Circ Res 107: 1058-1070, 2010.
7. Milne R and Brownstein S: Advanced glycation end products and diabetic retinopathy. Amino Acids 44: 1397-1407, 2013.
8. Xu H, Cai M and Zhang X: Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats. Graefes Arch Clin Exp Ophthalmol 253: 1485-1492, 2015.
9. Afzal N, Zaman S, Asghar A, Javed K, Shahzad F, Zafar A and Nagi AH: Negative association of serum IL-6 and IL-17 with type-II diabetes retinopathy. Iran J Immunol 11: 40-48, 2014.
10. Takeuchi M, Sato T, Tanaka A, Muraoka T, Taguchi M, Sakurai Y, Karasawa Y and Ito M: Elevated levels of cytokins associated with Th2 and Th17 cells in vitreous fluid of proliferative diabetic retinopathy patients. PLoS One 10: e0137358, 2015.
11. Nadeem A, Javaid K, Sami W, Zafar A, Jahan S, Zaman S and Nagi A: Inverse relationship of serum IL-17 with type-II diabetes retinopathy. Clin Lab 59: 1311-1317, 2013.
12. Afzal N, Zaman S, Shahzad F, Javaid K, Zafar A and Nagi AH: Immune mechanisms in type-2 diabetic retinopathy. J Pak Med Assoc 65: 159-163, 2015.
13. Longo VD and Kennedy BK: Sirtuins in aging and age-related disease. Cell 126: 257-268, 2006.
14. Li T, Zhang J, Feng J, Li Q, Wu L, Ye Q, Sun J, Lin Y, Zhang M, Huang R, et al: Resveratrol reduces acute lung injury in a LPS-induced sepsis mouse model via activation of Sirt1. Mol Med Rep 7: 1889-1895, 2013.
15. Sung B, Chung JW, Bae HR, Choi JS, Kim CM and Kim ND: Humulus japonicus extract exhibits antioxidative and anti-aging effects via modulation of the AMPK-SIRT1 pathway. Exp Ther Med 9: 1819-1826, 2015.
16. Balaiya S, Khetpal V and Chalam KV: Hypoxia initiates sirtuin1-mediated vascular endothelial growth factor activation in choroidal endothelial cells through hypoxia inducible factor-2α. Mol Vis 18: 114-120, 2012.
17. Zheng Z, Chen H, Li J, Li T, Zheng B, Zheng Y, Jin H, He Y, Gu Q and Xu X: Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects of metformin. Diabetes 61: 217-228, 2012.
18. Gardner PJ, Joshi L, Lee RW, Dick AD, Adamson P and Calder VL: SIRT1 activation protects against autoimmune T cell-driven retinal disease in mice via inhibition of IL-2/Stat5 signaling. J Autoimmun 42: 117-129, 2013.
19. Park YD, Kim YS, Jung YM, Lee SI, Lee YM, Bang JB and Kim EC: Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells. Cytokine 60: 284-293, 2012.
20. Alberti KG and Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med 15: 539-553, 1998.
21. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Der Pathologe 8: 138-140, 1987 (In German).
22. Wang C, Tian Y, Ye Z, Kijlstra A, Zhou Y and Yang P: Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease. Arthritis Res Ther 16: R117, 2014.
23. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, et al: Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196, 2003.
24. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
25. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q and Dong C: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141, 2005.
26. Sumarac-Dumanovic M, Jeremic D, Pantovic A, Janjetovic K, Stamenkovic-Pejkovic D, Cvijovic G, Stevanovic D, Micic D and Trajkovic V: Therapeutic improvement of glucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels. Immunobiology 218: 1113-1118, 2013.
27. Zizzo G, De Santis M, Bosello SL, Fedele AL, Peluso G, Gremese E, Tolusso B and Ferraccioli G: Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. Clin Immunol 138: 107-116, 2011.
28. Lynde CW, Poulin Y, Vender R, Bourcier M and Khalil S: Interleukin 17A: Toward a new understanding of psoriasis pathogenesis. J Am Acad Dermatol 71: 141-150, 2014.
29. Esendagli G, Kurne AT, Sayat G, Kilic AK, Guc D and Karabudak R: Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon β -1 therapy. J Neuroimmunol 255: 81-84, 2013.
30. Wong CK, Lit LC, Tam LS, Li EK, Wong PT and Lam CW: Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 127: 385-393, 2008.
31. Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H and Lotze MT: Interleukin-17 promotes angiogenesis and tumor growth. Blood 101: 2620-2627, 2003.
32. Suryawanshi A, Veiga-Parga T, Reddy PB, Rajasagi NK and Rouse BT: IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J Immunol 188: 3434-3446, 2012.
33. Chen Y, Yang P, Li F and Kijlstra A: The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells. PLoS One 6: e18139, 2011.
34. Lee SI, Min KS, Bae WJ, Lee YM, Lee SY, Lee ES and Kim EC: Role of SIRT1 in heat stress-and lipopolysaccharide-induced immune and defense gene expression in human dental pulp cells. J Endod 37: 1525-1530, 2011.
35. Kim YS, Lee YM, Park JS, Lee SK and Kim EC: SIRT1 modulates high-mobility group box 1-induced osteoclastogenic cytokines in human periodontal ligament cells. J Cell Biochem 111: 1310-1320, 2010.
36. + T-regulatory cell function and prolongs allograft survival. Mol Cell Biol 31: 1022-1029, 2011.
37. Maloney SC, Antecka E, Granner T, Fernandes B, Lim LA, Orellana ME and Burnier MN Jr: Expression of SIRT1 in choroidal neovascular membranes. Retina 33: 862-866, 2013.
38. Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS, Griffith D, Griffor M, Loulakis P and Pabst B: SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 285: 8340-8351, 2010.